Atai Life Sciences Inventory Turnover Ratio 2020-2023 | ATAI

Atai Life Sciences inventory turnover ratio from 2020 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Atai Life Sciences Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.357B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.978B 10.27
Quest Diagnostics (DGX) United States $15.146B 15.65
DaVita (DVA) United States $12.474B 15.49
Chemed (CHE) United States $8.473B 26.26
Encompass Health (EHC) United States $8.354B 21.50
Elanco Animal Health (ELAN) United States $6.655B 15.14
Option Care Health (OPCH) United States $5.195B 19.66
RadNet (RDNT) United States $3.817B 103.32
Amedisys (AMED) United States $3.020B 21.40
LifeStance Health (LFST) United States $2.496B 0.00
Astrana Health (ASTH) United States $2.077B 25.92
Addus HomeCare (ADUS) United States $1.611B 24.48
U.S Physical Therapy (USPH) United States $1.562B 40.48
Pennant (PNTG) United States $0.636B 37.19
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00